Showing 361 - 380 results of 1,132 for search '"immunosuppressant"', query time: 0.07s Refine Results
  1. 361

    Inflammatory demyelinating polyneuropathies and patient management during the COVID-19 pandemic. Literature review by R. Bunevičiūtė, A. Klimašauskienė

    Published 2020-06-01
    “…They can cause a lot of difficulties in daily practice due to their clinical heterogeneity and long term immunosuppressive treatment. Environmental and epidemiological changes may increase the incidence of the demyelinating polyneuropathies. …”
    Get full text
    Article
  2. 362

    The Controversial Role of Microglia in Malignant Gliomas by Jun Wei, Konrad Gabrusiewicz, Amy Heimberger

    Published 2013-01-01
    “…Mounting evidence indicates that the glioma microenvironment converts the glioma-associated microglia/macrophages (GAMs) into glioma-supportive, immunosuppressive cells; however, GAMs can retain intrinsic anti-tumor properties. …”
    Get full text
    Article
  3. 363
  4. 364

    Safety and Tolerance of Donor-Derived Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation: The MYSTEP1 Study by Steffen Hartleif, Michael Schumm, Michaela Döring, Markus Mezger, Peter Lang, Marc H. Dahlke, Joachim Riethmüller, Alfred Königsrainer, Rupert Handgretinger, Silvio Nadalin, Ekkehard Sturm

    Published 2017-01-01
    “…Our secondary objective is to evaluate efficacy of MSC treatment as measured by the individual need for immunosuppression and the incidence of biopsy-proven acute rejection. …”
    Get full text
    Article
  5. 365

    Emicizumab in two patients with acquired haemophilia A – case report by Zhao Milly, Kartika Thomas, Witenko Corey, Snead Jessica, DeSancho Maria T, Ciolek Alana

    Published 2024-08-01
    “…Patients with acquired haemophilia A (PwAHA) can present with severe bleeding and may require lengthy treatment with bypassing agents and immunosuppression. We present two cases of the implementation of emicizumab in PwAHA. …”
    Get full text
    Article
  6. 366

    A Case of De Novo Antiglomerular Basement Membrane Disease Presenting during Pregnancy by F. A. K. Lodhi, T. Akcan, J. N. Mojarrab, S. Sajjad, R. Blonsky

    Published 2021-01-01
    “…Fetal safety should be considered and risks thoroughly discussed with the patient when choosing an immunosuppressive regimen for this condition.…”
    Get full text
    Article
  7. 367

    Management and Clinical Outcome of Penetrating Keratoplasty for Long-Term Corneal Changes in Sympathetic Ophthalmia by Saraswathi Ramamurthi, Ebube E. Obi, Gordon N. Dutton, Kanna Ramaesh

    Published 2011-01-01
    “…Our patients were immunosuppressed prior to the procedure to help prevent graft rejection. …”
    Get full text
    Article
  8. 368
  9. 369

    Group 2 Innate Lymphoid Cells Are Involved in Skewed Type 2 Immunity of Gastric Diseases Induced by Helicobacter pylori Infection by Rong Li, Xiao-xia Jiang, Lin-fang Zhang, Xiao-ming Liu, Ting-zi Hu, Xiu-juan Xia, Ming Li, Can-xia Xu

    Published 2017-01-01
    “…In conclusion, our results indicated that ILC2-mediated innate immune response might play a potential role in dominant type 2 phenotype and immunosuppressive microenvironment in H. pylori infection.…”
    Get full text
    Article
  10. 370
  11. 371

    A Case of Phlegmonous Gastritis in a Patient with Psoriatic Arthritis on Infliximab by Laurence De Davide, Annie Beaudoin

    Published 2018-01-01
    “…We thereby describe the case of a 42-year-old male patient known for psoriatic arthritis on Infliximab who was diagnosed with phlegmonous gastritis secondary to immunosuppressive therapy. The patient had a favourable outcome with a conservative treatment consisting of a 14-day course of broad antibiotherapy.…”
    Get full text
    Article
  12. 372

    A Rare and Potentially Catastrophic Infection: Primary Intestinal Aspergillosis—Case Report in an HIV Patient by Cátia Dias, Filipa Duarte-Ribeiro, Sara Pipa, Margarida Mota

    Published 2018-01-01
    “…Aspergillus species are ubiquitous in nature; however, infection is uncommon, except in immunocompromised or immunosuppressed hosts. We present the case of a 71-year-old woman with a history of human immunodeficiency virus infection who presented with fever, weight loss, and diarrhea, posteriorly diagnosed with intestinal aspergillosis after examination of a segmental enterectomy piece. …”
    Get full text
    Article
  13. 373

    Tissue-Related Hypoxia Attenuates Proinflammatory Effects of Allogeneic PBMCs on Adipose-Derived Stromal Cells In Vitro by Polina I. Bobyleva, Elena R. Andreeva, Aleksandra N. Gornostaeva, Ludmila B. Buravkova

    Published 2016-01-01
    “…ASC/PBMCs interaction resulted in anti-inflammatory shift of paracrine mediators in conditioning medium with significant increase of immunosuppressive LIF level. Our data indicated that under both ambient and tissue-related O2 ASCs possessed immunosuppressive potential and maintained functional activity. …”
    Get full text
    Article
  14. 374

    Diffuse Alveolar Hemorrhage in Patients with Systemic Lupus Erythematosus: A Single Center Retrospective Study in Malaysia by Piem Jie Leong, Anna Farazilah Mohd Salleh

    Published 2024-12-01
    “…However, a combination of multiple immunosuppressive agents appeared to be associated with better outcomes in some patients.…”
    Get full text
    Article
  15. 375

    A Challenging Twist in Pulmonary Renal Syndrome by Rajaie Namas, Bernard Rubin, Wamidh Adwar, Alireza Meysami

    Published 2014-01-01
    “…Prompt cessation of hydralazine may be sufficient to reverse disease activity but immunosuppression may be needed.…”
    Get full text
    Article
  16. 376

    Sirolimus Enhances Cyclosporine A-Induced Cytotoxicity in Human Renal Glomerular Mesangial Cells by Séin O'Connell, Craig Slattery, Michael P. Ryan, Tara McMorrow

    Published 2012-01-01
    “…This work addressed nephrotoxicity induced by the immunosuppressive agents’ cyclosporine A (CsA) and sirolimus (SRL). …”
    Get full text
    Article
  17. 377

    Orbital and adnexal sarcoidosis: Clinical presentations and management outcomes by Shebin Salim, Md Shahid Alam, Sonam Ahuja, Kirthi Koka, Marian Pauly, Subramanian Krishnakumar, Bipasha Mukherjee

    Published 2025-02-01
    “…Additional treatments included oral steroids (n = 10) and systemic immunosuppressants (n = 5). Six patients were lost to follow-up. …”
    Get full text
    Article
  18. 378

    Microglia-secreted TNF-α affects differentiation efficiency and viability of pluripotent stem cell-derived human dopaminergic precursors. by Shirley D Wenker, María Isabel Farias, Victoria Gradaschi, Corina Garcia, Juan Beauquis, María Celeste Leal, Carina Ferrari, Xianmin Zeng, Fernando J Pitossi

    Published 2023-01-01
    “…We first observed that transplanted human dopaminergic precursors into the striatum of immunosuppressed rats elicited an early and sustained activation of astroglial and microglial cells after 15 days' post-transplant. …”
    Get full text
    Article
  19. 379

    Identifying RBBP7 as a Promising Diagnostic Biomarker for BK Virus-Associated Nephropathy by Yicun Wang, Yuxuan Wang, Di Zhang, Hao Zhang, Wei Wang, Xiaopeng Hu

    Published 2022-01-01
    “…BK virus-associated nephropathy (BKVN) remains a major infectious complication due to powerful immunosuppression in kidney transplant recipients, and its histologic appearance can mimic rejection, leading to diagnostic and treatment dilemmas thus molecular diagnostic methods would be beneficial. …”
    Get full text
    Article
  20. 380

    BK Virus Load Associated with Serum Levels of sCD30 in Renal Transplant Recipients by Haidar A. Shamran, Salma N. Malik, Jinan M. Al-Saffer, Rana S. Jawad

    Published 2016-01-01
    “…These results suggest that serum levels of sCD30 could be used as an indicator of BK viremia, and accordingly the immunosuppressive regime should be adjusted.…”
    Get full text
    Article